CONTACT:
Simon Castellanos
877.443.4006
AIS Healthcare reaffirms commitment to improving the lives of patients living with chronic pain
Dallas, TX – AIS Healthcare, the leading provider of targeted drug delivery (TDD) and infusion care solutions, is proud to recognize September as Pain Awareness Month. Throughout this month, AIS Healthcare aims to raise awareness about the challenges faced by individuals living with chronic pain and highlight the importance of accessible and effective pain management solutions. In the United States, chronic pain is a widespread issue affecting more than 51 million Americans. AIS Healthcare serves some of the most vulnerable chronic pain patients through TDD, offering patients customized medications from our state-of-the-art pharmacies and care from highly trained nursing staff across the country.
Our cutting-edge treatment empowers patients to manage their pain effectively and lead full and active lives. As a leading provider in the pain management field, AIS Healthcare goes beyond traditional methods, offering innovative and compassionate solutions that aim to bring relief to those who need it most. During Pain Awareness Month and beyond, AIS Healthcare is committed to raising standards of care, quality, and safety across the industry to positively impact our patients’ quality of life.
“We pride ourselves on supporting patients to live with less pain, enabling them to be fully present and active with their families and in their communities. Our state-of-the-art quality and safety standards are critical to alleviating the burden of pain for our patients and restoring hope for those managing chronic conditions,” said Simon Castellanos, Chief Executive Officer of AIS Healthcare. “Our approach goes beyond merely addressing the physical aspects of pain; we recognize the emotional toll it takes on individuals and their families.By consistently raising the bar for excellence in targeted drug delivery and infusion care, we can truly transform our patients’ lives by dramatically improving their quality of life.”
Since being established in 2008, AIS Healthcare has been delivering care that puts patients first. At every step of a patient’s care, AIS Healthcare aims to be a supportive partner by delivering customized medications and personalized services while ensuring the patient’s emotional and psychological well-being are cared for as well.
AIS Healthcare is dually accredited by URAC and the Accreditation Commission for Health Care (ACHC), further setting it apart from other compounding pharmacies and infusion services providers. AIS Healthcare continues to deliver transformative services across the care continuum for its patients.
About AIS Healthcare
Advancing quality. Improving lives.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com.
CONTACT:
Jud Hall
877.443.4006
AIC’s new pharmacy will better serve patients and physicians across the Mid-Atlantic
Dallas, TX – Advanced Infusion Care (AIC), a division of AIS Healthcare, today announced the opening of a new pharmacy location in Cockeysville, Maryland. This continued expansion to the Northeast provides a platform for the company to serve more patients and physicians in the region. The Maryland pharmacy is AIC’s sixth location from which the company dispenses essential medications and personalized care to patients across the United States with complex medical conditions like immune deficiency diseases.
The newly opened pharmacy is strategically positioned and designed to cater to the unique needs of patients and providers in the Mid-Atlantic. With a firm commitment to elevating the patient experience, AIC aims to make medications and home infusion services more accessible to those in need of care solutions.
“We are thrilled to open a pharmacy location in Maryland. This expansion is a testament to AIC’s unwavering dedication to our patients and our vision of providing best-in-class healthcare services with a personal touch. By opening this location, we aim to streamline the medication fulfillment process, enhance convenience, and ultimately improve the lives of our patients,” said Jud Hall, President at AIC.
With a focus on efficiency and compassion, AIC is committed to addressing the unique medication needs of each patient and fostering strong relationships with healthcare providers in the area. The fully operational pharmacy in Maryland has started dispensing its extensive inventory of prescription medications, over-the-counter products, and specialty medications to patients. The location utilizes cutting-edge technology and a team of highly skilled pharmacists and healthcare professionals to serve patients. The facility also features a state-of-the-art USP797-compliant cleanroom which is critical to ensuring sterility and quality in the medications.
In recent months, AIC announced further expansion into the New England market and the grand reopening of a newly designed pharmacy in Valdosta, Georgia. AIC also made medications like GAMMAKED™ and LEQEMBI™ available to patients through its locations in Valdosta, Georgia; Birmingham, Alabama; Clinton, Mississippi; Panama City, Florida; and Dallas, Texas.
Physicians interested in AIC care services should contact their AIC representatives to get started or visit us at www.aiscaregroup.com/our-divisions/infusion-care/.
Advancing quality. Improving lives.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com
CONTACT:
Jud Hall
877.443.4006
Advanced Infusion Care’s Nurse Specialists and In-Home Infusion Care Offerings Extended to Cover Connecticut, Massachusetts, and Rhode Island
Dallas, TX – Advanced Infusion Care (AIC), a division of AIS Healthcare, today announced the expansion of its nurse specialists and in-home infusion care offerings to Connecticut, Massachusetts, and Rhode Island. With its expansion to cover more of the New England market, AIC’s network of 180 nurses is now present in 40 states. AIC’s pharmacists and nursing team will offer a comprehensive suite of medications and services for patients with complex medical conditions like immune deficiency diseases.
By providing a team-based approach to intravenous and subcutaneous immunoglobulin (Ig) therapy, AIC delivers specialized treatment options to individuals living with immunodeficiencies and other complex conditions. For these patients, Ig therapy enables them to fight infections, stay healthy, and receive care in the comfort of their own homes. All patients in the expanded territory will have access to 24/7 nurse availability for education, care coordination, medication management, and more.
“Our growth into the New England market will allow AIC’s talented team of infusion nurse specialists to support even more patients,” said Jud Hall, President at AIC. “Our team of nationally accredited home infusion specialists will help ensure each individual’s specific clinical and personal needs are met, driving better outcomes for all of our patients.”
AIS Healthcare is dually accredited by URAC and the Accreditation Commission for Health Care (ACHC), further setting it apart from other infusion services providers. AIC is also a member of the Immunoglobulin National Society and is regularly inspected by national and state boards of pharmacy.
In recent months, AIC announced the grand reopening of a newly designed pharmacy in Valdosta, Georgia. AIC continues to add cutting edge medications available to patients through its locations in Valdosta, Georgia; Birmingham, Alabama; Clinton, Mississippi; Panama City, Florida; and Dallas, Texas.
Physicians interested in AIC care services should contact their AIC representatives to get started or visit us at www.aiscaregroup.com/our-divisions/infusion-care/.
Advancing quality. Improving lives.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com
Contact:
Simon Castellanos
877.443.4006
Targeted Drug Delivery and Infusion Care Solutions Provider Commemorates Milestone of Providing Patient-Centered Care
Dallas, Texas – AIS Healthcare, the leading provider of targeted drug delivery and infusion care solutions, celebrates fifteen years of delivering high quality patient care. Established in 2008 in Dallas, Texas, AIS Healthcare has grown to eight locations across six states supporting more than 35,000 patients throughout the country. The company’s state-of-the-art compounding pharmacies and highly trained pharmacists produce medications of the highest quality and sterility that enhance patient quality of life and lead to better outcomes.
“For the past fifteen years, AIS Healthcare has delivered care and support for our patients that makes their days easier and lives better. We go beyond what is expected to set higher quality standards for targeted drug delivery and infusion care, enabling an improved quality of life for our patients,” said Simon Castellanos, AIS Healthcare Chief Executive Officer.“AIS Healthcare looks forward to continuing the important work of improving the lives of the patients and physicians we serve.”
AIS Healthcare compounds patient-specific prescriptions at its state-of-the-art 503A specialty pharmacies for its targeted drug delivery (TDD) division and provides personalized services for both patients and physicians. Utilizing AIS Healthcare’s TDD medication and services helps patients better manage chronic pain and spasticity to improve daily functionality.
Additionally, AIS Healthcare’s Advanced Infusion Care (AIC) division offers a comprehensive suite of services for patients with complex medical conditions like primary immunodeficiency and is supported by its team of highly trained nurses. AIC applies a team-based approach to intravenous and subcutaneous immunoglobulin therapy patient care with locations in Mississippi, Alabama, Georgia, Texas, Florida and Maryland.
AIS Healthcare is dually accredited by URAC and the Accreditation Commission for Health Care (ACHC), further setting it apart from other compounding pharmacies and infusion services providers. As the industry leader in targeted drug delivery and infusion care, AIS Healthcare continues to deliver transformative services across the care continuum for its patients.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com
Contact:
Simon Castellanos
877.443.4006
Targeted drug delivery and infusion care solutions improve patient quality of life and increase physical activity to promote health and wellness among seniors
Dallas, Texas – AIS Healthcare, the leading provider of targeted drug delivery and infusion care solutions, recognizes today as the 30th annual National Senior Health & Fitness Day. The medication and services provided by AIS Healthcare Targeted Drug Delivery (TDD) and Advanced Infusion Care (AIC) empower seniors to live healthy and productive lives by helping manage severe pain, spasticity, and other chronic health conditions. National Senior Health & Fitness Day, celebrated on the last Wednesday of May, is a day dedicated to the wellness of seniors with the common goal of helping keep American seniors fit and healthy.
Seniors utilizing TDD through AIS Healthcare report improvement with their pain, spasticity, physical functionality, and quality of life. The goal of the therapy is to minimize pain and allow patients to regain their ability to participate in daily activities. Patients managing chronic pain and spasticity represent an extremely high-risk group prone to hospitalization, urgent care visits, and surgeries that often fail.
At AIC, a division of AIS Healthcare, infusion therapies help treat patients with a range of medical conditions including primary immunodeficiency, lung problems, and autoimmune diseases. For seniors living with these conditions, infusion therapies help to manage their treatments effectively and live a full life.
“Our patients are at the center of everything we do. At AIS Healthcare, we strive to meet the highest standards of safety and quality in our medications and services so that we meaningfully improve the lives of all our patients. We are committed to providing seniors with best-in-class care that increases their physical activity and improves their overall health and wellness,” said Simon Castellanos, AIS Healthcare Chief Executive Officer.
National Senior Health & Fitness Day is the largest health and wellness movement for seniors in the U.S., celebrated across senior centers, hospitals, health clubs, retirement communities, and more. This May 31, 2023, marks a time to celebrate the contributions of seniors to our communities and renew our efforts to keep them healthy and thriving.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com
CONTACT:
Jud Hall
877.443.4006
Advanced Infusion Care (AIC) now offers Eisai infusion therapy LEQEMBI™ (Lecanemab-irmb) humanized immunoglobulin gamma 1 (IgG1) monoclonal antibody.
Dallas, TX- Advanced Infusion Care, a division of AIS Healthcare, now offers LEQEMBI™, developed by Eisai Co., Ltd., for the treatment of patients with Alzheimer’s disease.
The nationally accredited home infusion teams at AIC collaborate closely with physicians to provide specialized infusion services to patients in their home or at an infusion suite setting. This new therapy option expands AIC’s ability to better serve Alzheimer’s patients.
“We’re proud to be able to add LEQEMBI to our growing list of infusion therapies,” said Jud Hall, President at AIC. “This therapy from Eisai can help us provide a new treatment option for patients with Alzheimer’s disease.”
LEQEMBI is indicated for the treatment of Alzheimer’s disease. Treatment with LEQEMBI should be initiated in patients with mild cognitive impairment or mild dementia stage of disease, the population in which treatment was initiated in clinical trials. There are no safety or effectiveness data on initiating treatment at earlier or later stages of the disease than were studied. This indication is approved under accelerated approval based on reduction in amyloid beta plaques observed in patients treated with LEQEMBI. Continued approval for this indication may be contingent upon verification of clinical benefit in a confirmatory trial.
Approved at 100 mg/mL injection for intravenous use by the U.S Food and Drug Administration on January 6, 2023, the therapy is now available at all AIC locations (Valdosta, Georgia; Birmingham, Alabama; Clinton, Mississippi; Panama City, Florida; Dallas, Texas).
Like all AIC patients, those with Alzheimer’s disease will receive a high level of care from AIC, including 24/7 access to clinical and support staff. Every patient is assigned a dedicated team of professionals, including clinical pharmacists, infusion nurse specialists, and intake managers to provide support throughout the treatment process.
For physicians, AIC is a full-service care delivery partner. We also work directly with patients, insurance companies, and physician offices to secure all needed authorizations and complete paperwork.
AIS Healthcare is dually accredited by URAC and the Accreditation Commission for Health Care (ACHC), further setting it apart from other infusion services providers.
Physicians interested in AIC care services should contact their AIC representatives to get started or visit us at www.aiscaregroup.com/our-divisions/infusion-care/
Advancing quality. Improving lives.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com.
CONTACT:
Pam Carter
877.443.4006
Case study highlights Advanced Infusion Care and AIS Healthcare’s commitment to patients and quality of care
Dallas, TX – Advanced Infusion Care (AIC), a division of AIS Healthcare, today announced a recent feature in the National Home Infusion Association’s (NHIA) Infusion Journal. The case study in NHIJ, coauthored by Amy Mulgrew (RN, CRNI, IgCN, VA-BC), Erin Mullis (RN, IgCN), and Ashley McKenna (RN, IgCN) details the experience of an AIC patient diagnosed with chronic variable immunodeficiency (CVID) and underscores the importance of considering patient preference when choosing the optimal immune globulin (Ig) therapy approach.
“Patients living with primary immunodeficiency (PI) deserve individualized treatment options that maximize patient health and quality of life. Our case study highlighted in the NHIJ is a prime example of prioritizing patient-specific needs while also heeding patient choice,” said Amy Mulgrew, National Manager of Clinical Education at Advanced Infusion Care.
For patients with PI and CVID, rare genetic disorders that impair the immune system, Ig is a lifelong therapy that enables patients to fight infections, stay healthy, and receive care in the comfort of their own homes. In the case study, the AIC patient began intravenous immunoglobulin (IVIg) therapy and transitioned to subcutaneous immune globulin (SCIg) therapy before transitioning back to IVIg for quality-of-life reasons and personal preferences.
Both IVIg and SCIg are clinically proven effective treatments for PI, and they each offer certain advantages and disadvantages. That is why it is important to assess the patient’s unique circumstances to help guide decisions for intravenous or subcutaneous treatment. Ig therapy must be individualized to meet each patient’s specific clinical needs as well as their personal preferences.
The AIC patient cited in the case study underwent treatment from 2015-2020, with monthly IVIg infusions generally well tolerated. The patient experienced mild to moderate adverse drug reactions (ADRs), described as fatigue and lethargy, and then in 2020 requested a transition to SCIg to determine if that route of administration could effectively treat his CVID without the ADRs experienced using IVIg. In late 2021, the patient noted numerous ADRs from his weekly SCIg infusions and stated he felt better on the monthly infusion of IVIg.
Since transitioning back from SCIg to IVIg, the patient remained stable and has had no reported ADRs. AIC nurses have visited him and noted that the patient’s quality of life has improved. In this instance, AIC was able to accommodate the patient’s preference and that helped lead to improved patient satisfaction.
“Clinicians and care providers can better serve patients if Ig care is individualized. This patient case study highlights the importance of recognizing patient preference when choosing the route of administration for Ig therapy,” added Mulgrew.
The Infusion Journal is a peer reviewed, scholarly publication that features independent original research and studies on the effects of infusion therapies related to patient outcomes, medication safety, economic analyses, drug stability studies, case studies, and evaluations of innovative clinical services.
The full AIC case study in the Infusion Journal is available here.
About AIS Healthcare
Advancing quality. Improving lives.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com
Contact:
Simon Castellanos
877.443.4006
Dallas, Texas – AIS Healthcare, the leading provider of targeted drug delivery and infusion care solutions, is proud to recognize May 6th – 12th as National Nurses Week. National Nurses Week brings attention to four focus areas — Self-Care, Recognition, Professional Development, and Community Engagement. AIS Healthcare honors the contributions, dedication, and sacrifices of these critical medical professionals as they work to improve the lives of their patients.
“I express the company’s utmost gratitude and respect for all the nurses at AIS Healthcare who serve our patients diligently. The services we provide to our patients would not be possible without the hard work and dedication of our nursing staff. Across the country, AIS Healthcare’s nurses offer comprehensive care services that improve their patients’ quality of life. We celebrate our team’s contributions during Nurses’ Week, and every week,” said Pam Carter, AIS Healthcare’s Chief Nursing Officer.
Nurses conduct some of the most difficult work in the healthcare industry, performing essential tasks and serving as the first point of contact for many patients. AIS Healthcare celebrates the more than 250 nurses on our staff that play an important role in advancing quality and improving outcomes for our patients.
Advancements in science and medical technology have dramatically expanded the role of nurses in the healthcare system. Recent crises, particularly the COVID-19 pandemic, have also underscored the crucial role nurses play both in the healthcare industry and in society. From emergency response to caring for the elderly and newborn, nurses perform some of the most difficult tasks in the medical world.
Their service to patients is commended during this National Nurses Week and throughout the year. To learn more about National Nurses Month and Week please visit the American Nurses Association website here.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com
Contact:
Simon Castellanos
877.443.4006
Thomas Young to serve as AIS Healthcare’s Deputy General Counsel and Deputy Chief Compliance Officer
Dallas, Texas – AIS Healthcare, the leading provider of targeted drug delivery and infusion care solutions, today announced the hiring of Thomas Young as Deputy General Counsel and Deputy Chief Compliance Officer. In this role, Thomas will drive AIS Healthcare’s legal strategy, help oversee the company’s regulatory and compliance programs, and lead engagement with state and federal regulators.
“We are thrilled to welcome an experienced and highly respected member of the healthcare industry to the AIS Healthcare team,” said John Finley, AIS Healthcare’s General Counsel and Chief Compliance Officer. “Thomas will bring a valuable perspective to the company and serve as a trusted advisor as we continue to raise the bar for delivering the safest and highest-quality care to our patients.”
Young brings more than 30 years of executive experience in the healthcare industry to AIS Healthcare with a focus on navigating complex regulatory environments. Recently, Young served in a senior role at Cigna Health as the company’s Medicare Compliance Officer. Previously, Young spent over 25 years at Aetna Health where he served in various compliance and regulatory roles, including Chief Compliance Officer.
“I’m excited to join AIS Healthcare’s industry leading team and offer my experience to further enhance the company’s efforts to advance quality and compliance standards for specialty pharmacies,” said Thomas Young, AIS Healthcare’s Deputy General Counsel and Deputy Chief Compliance Officer. “I’m proud to be part of a team that is committed to offering the safest and highest-quality treatments and services to dramatically improve the lives of patients suffering from severe chronic pain, spasticity, and immunodeficiency diseases.”
Young holds a J.D. from Duke University’s School of Law and an undergraduate degree from Princeton University.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com.
We are pleased to announce that Natalie DeGroff, MS, RN, FNP-C, our Senior Director of Targeted Drug Delivery (TDD) Nursing Operations, has been selected as one of the 14 qualified nurse practitioners (NPs) for the American Association of Nurse Practitioners (AANP) Executive Leadership Program Cohort. This program helps high-potential NPs develop a strategic mindset and multiply their impact as leaders across their organizations.
Natalie brings more than 16 years of experience to her role at AIS Healthcare. Previously a pain management NP, she has worked in hospital, ambulatory, health call center, home infusion and specialty pharmacy settings. Natalie is an invaluable member of the AIS Healthcare team and her selection to the AANP reflects her exemplary work ethic in the TDD landscape.
“Natalie is a proven, versatile, and engaging leader,” said Pam Carter, Chief Nursing Officer at AIS Healthcare. “AIS Healthcare is fortunate to have nursing leadership of this caliber. This is a well-deserved recognition and accomplishment for Natalie.”
The American Association of Nurse Practitioners® (AANP) is the largest professional membership organization for NPs of specialties. It represents the interests of more than 355,000 licensed NPs in the U.S. The AANP advances health policy through legislative leadership at the local, state, and national levels; promotes excellence in practice, education, and research; and builds standards that best serve NPs’ patients and other healthcare consumers.
Advancing quality. Improving lives.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.